Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study.
Patients with Alzheimer's disease after an initial response to cholinesterase inhibitors may complain a later lack of efficacy. This, in association with incident neuropsychiatric symptoms, may worsen patient quality of life. Thus, the switch to another cholinesterase inhibitor could represent...
Main Authors: | Gianfranco Spalletta, Carlo Caltagirone, Alessandro Padovani, Sandro Sorbi, Mahmood Attar, Delia Colombo, Luca Cravello, E V O L U T I O N study Working Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3929703?pdf=render |
Similar Items
-
Good rate of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease after three months of treatment: An open-label study
by: Luis Felipe José Ravic de Miranda, et al. -
Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
by: Paola Bossù, et al.
Published: (2018-11-01) -
Cholinesterases in Alzheimer's disease
by: Navaratnam, Dasakumar Selveraj
Published: (1990) -
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
by: Martina Zimmermann, et al.
Published: (2005-06-01) -
Myeloid dendritic cells are potential players in human neurodegenerative diseases
by: Paola eBossù, et al.
Published: (2015-12-01)